Stéphane Bancel, the CEO of Moderna, in Marseille, France, this week. FRANCE KEYSER for The Wall Street JournalInside Moderna: The Covid Vaccine Front-Runner With No Track Record and an Unsparing CEO The upstart hasn’t yet developed an approved drug, its chief can be excoriating and until recently investors were disillusioned. A breakthrough coronavirus vaccine could come in trials starting this month.

Source: Wall Street Journal July 01, 2020 14:54 UTC